Komori
Immuno-Biological Laboratories (4570) · InitiativeFirst stated

Contract testing services for lipid metabolism research using PXB-cells LA

First written in FY2023. . Latest entry: FY2023.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Contract testing for lipid metabolism research using PXB-cells LAA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2023First statedAnnual report

    「In addition to its partnership with a major testing company, the company began offering contract testing services using “PXB-cells LA,” a material for lipid metabolism research, through a business partnership with PhoenixBio Co.,Ltd. It will continue to provide contract testing services on a stable basis while expanding them.」

    Through a business partnership with フェニックスバイオ, we launched contract testing services using PXB-cells LA and aim to stabilise and expand our contract testing business.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Immuno-Biological Laboratories yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.